The prognosis of cryptogenic fibrosing alveolitis.
D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D001706:Biopsy; D001984:Bronchial Neoplasms / Q000150:complications; D002318:Cardiovascular Diseases / Q000150:complications; D004417:Dyspnea / Q000150:complications; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D000860:Hypoxia / Q000150:complications; D008168:Lung / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011658:Pulmonary Fibrosis / Q000150:complications / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000401:mortality; D011859:Radiography; D012217:Rheumatoid Factor / Q000032:analysis; D014797:Vital Capacity
D000974:Antibodies, Antinuclear; D005938:Glucocorticoids; D012217:Rheumatoid Factor